300439.SZ SHZ
Medicalsystem Biotechnology Co., Ltd.
1W: +1.7%
1M: +7.7%
3M: +22.8%
YTD: -1.0%
1Y: -13.0%
3Y: -5.9%
5Y: -45.6%
¥10.25 ($1.53)
+0.11 (+1.08%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$3.7B
+6.2% ▲
5Y CAGR: -0.2%
Total Liabilities
$772M
-1.4% ▼
5Y CAGR: -20.0%
Shareholders Equity
$2.9B
+8.3% ▲
5Y CAGR: +17.1%
Cash & Investments
$890M
-7.8% ▼
5Y CAGR: +15.3%
Total Debt
$67M
-8.8% ▼
5Y CAGR: -46.3%
Net Debt
-$662M
+22.2% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $328M | $666M | $806M | $959M | $729M |
| Short-Term Investments | $0 | $101M | $80M | $6M | $161M |
| Cash & ST Investments | $328M | $767M | $887M | $965M | $890M |
| Net Receivables | $867M | $874M | $892M | $630M | $573M |
| Inventory | $254M | $211M | $0 | $259M | $286M |
| Other Current Assets | $120M | $304M | $231M | $601K | $46M |
| Total Current Assets | $1.6B | $2.0B | $2.1B | $1.9B | $1.8B |
| Property, Plant & Equip. | $1.0B | $1.0B | $1.1B | $1.2B | $1.4B |
| Goodwill & Intangibles | $177M | $148M | $120M | $128M | $135M |
| Long-Term Investments | $390M | $84M | $83M | $212M | $30M |
| Other Non-Current Assets | $36M | $262M | $219M | $36M | $259M |
| Total Non-Current Assets | $1.7B | $1.6B | $1.5B | $1.6B | $1.9B |
| Total Assets | $3.3B | $3.6B | $3.6B | $3.5B | $3.7B |
| — Liabilities — | |||||
| Accounts Payable | $277M | $331M | $374M | $333M | $369M |
| Short-Term Debt | $782M | $340M | $218M | $50M | $30M |
| Deferred Revenue | $272M | $308M | $77M | $0 | $0 |
| Other Current Liabilities | $267M | $330M | -$5M | $315M | $265M |
| Total Current Liabilities | $1.4B | $1.1B | $981M | $699M | $667M |
| Long-Term Debt | $97M | $45M | $7M | $0 | $0 |
| Other Non-Current Liab. | -$16M | $0 | $14M | $11M | $4M |
| Total Non-Current Liabilities | $178M | $141M | $83M | $83M | $104M |
| Total Liabilities | $1.6B | $1.2B | $1.1B | $782M | $772M |
| — Equity — | |||||
| Common Stock | $343M | $383M | $383M | $383M | $384M |
| Retained Earnings | $632M | $752M | $914M | $1.1B | $1.3B |
| Accumulated OCI | $146M | $145M | $146M | -$29M | $173M |
| Total Stockholders Equity | $1.6B | $2.3B | $2.5B | $2.7B | $2.9B |
| Total Liabilities & Equity | $3.3B | $3.6B | $3.6B | $3.5B | $3.7B |
| — Key Metrics — | |||||
| Total Debt | $927M | $482M | $332M | $74M | $67M |
| Net Debt | $598M | -$184M | -$475M | -$851M | -$662M |
| Total Investments | $390M | $184M | $163M | $218M | $191M |